3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
The structures of the highly homologous type I and II 3 beta-HSD genes have been analyzed in three male pseudohermaphrodite 3 beta-HSD deficient patients from unrelated families in order to elucidate the molecular basis of classical 3 beta-HSD deficiency from patients exhibiting various degrees of severity of salt losing.
|
8316254 |
1993 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that the degree of ACTH-stimulated delta 5 precursor steroid abnormality, such as delta 5-17P levels up to 10 SD above the normal mean level found in our PP patients, is not caused by a mild variant of 3 beta HSD deficiency CAH resulting from type II or type I 3 beta HSD gene mutation.
|
8923844 |
1996 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Molecular DNA analysis was also performed in 6 of the patients, using the strategy successfully used to detect point mutations in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene, which are responsible for classical 3 beta HSD deficiency.
|
7989489 |
1994 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, a structurally lengthy MT II 3beta-HSD enzyme due to a nonstop mutation was relatively detrimental in intact cells causing the nonclassic phenotype of 3beta-HSD deficiency.
|
12050213 |
2002 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These data indicate a homozygous combined missense/frameshift mutation in exon IV of the type II 3 beta-HSD gene resulting in severe salt-wasting adrenal and gonadal 3 beta-HSD deficiency in the patient.
|
8284113 |
1993 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In hyperandrogenic children and women, the pathogenic mechanism of a subtle abnormality in adrenal 3 beta-HSD activity, determined by modestly elevated ACTH stimulated delta-5 steroid levels, which led to the diagnosis of mild nonclassic 3 beta-HSD deficiency in the past, is outside of the type II 3 beta-HSD gene which encodes adrenals and gonads in humans and remains to be further explored.
|
11344940 |
2001 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We report mutations of the type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene in two siblings, male and female, with congenital adrenal hyperplasia caused by classical nonsalt-losing 3 beta HSD deficiency.
|
7962268 |
1994 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
To better understand the molecular basis of the phenotypic heterogeneity found in 3 beta HSD deficiency, we analyzed the structure of type I and II 3 beta HSD genes in a female patient with nonsalt-losing 3 beta HSD deficiency diagnosed at puberty.
|
8126127 |
1994 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Both codon 273 and 318 mutations yielding frameshift and premature stop codons at codons 279 and 367, respectively, are predicted to result in an altered and truncated type II 3 beta-HSD protein, thereby causing salt-wasting 3 beta-HSD deficiency in the patient.
|
8550766 |
1996 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results indicate that the genital phenotype in 3beta-HSD deficiency cannot be predicted from in vitro 3beta-HSD function alone.
|
18252794 |
2008 |
3 beta-Hydroxysteroid dehydrogenase deficiency
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, the elucidation of the molecular basis of 3beta-HSD deficiency has highlighted the fact that mutations in the HSD3B2 gene can result in a wide spectrum of molecular repercussions, which are associated with the different phenotypic manifestations of classical 3beta-HSD deficiency and also provide valuable information concerning the structure-function relationships of the 3beta-HSD superfamily.
|
12428206 |
2002 |
3-Beta-hydroxy-delta-5-C27-steroid dehydrogenase deficiency
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
No linkage to the 3 beta-HSD gene cluster in a kindred affected with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency and early onset hepatic failure.
|
7759084 |
1995 |
Abnormal form of the vertebral bodies
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of cardiovascular system morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the abdominal wall
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormally large globe
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acquired cubitus valgus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acute Promyelocytic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here we reported 1 patient with APL with CHST3 mutations.
|
30200136 |
2018 |
Adenoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In vitro enzyme assay using microsomal fraction of adenoma indicated that all adenomas from seven patients showed almost the same degree of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) activities.
|
8496319 |
1993 |
Adrenal Gland Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Histopathological analysis of the resected adrenal tumors from 5 PA/SCS patients revealed a single adenoma in 3, and double adenomas in 2, with varying degrees of positive immunoreactivities for steroidgenic enzymes (3β-HSD, P450(C17)) by immunohistochemical study as well as CYP11B2 mRNA expression as measured by real-time RT-PCR.
|
21521926 |
2011 |
Adrenocortical carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
EGF treatment (25 ng/ml) of human adrenocortical carcinoma cells (H295R) resulted in a 5-fold increase in cortisol production and a corresponding 2-fold increase in 3 beta HSD mRNA.
|
12697691 |
2003 |
Adrenoleukodystrophy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Previously we have shown higher urinary F:E metabolite ratios (a reflection of global 11beta-HSD activity) in patients with alcoholic liver disease (ALD) compared to patients with chronic liver disease (CLD) of other aetiologies, suggesting that the phenotype of alcoholic pseudo-Cushing's may relate to altered metabolism of F.
|
18031327 |
2008 |
Adult Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Osteosarcoma-derived OB cell lines TE-85, MG-63 and SaOS-2 and fibrosarcoma Hs913T cells express the type 2 isoform of 11beta-HSD, as determined by reverse transcription polymerase chain reaction (RT-PCR) and specific enzyme assays.
|
10333548 |
1999 |
Advanced bone age
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|